Publication | Closed Access

Double high-dose therapy for Hodgkin's disease with dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP) prior to high-dose melphalan and autologous stem cell transplantation

Cell TherapyTransplantationMarrow TransplantationMedicineImmunosuppressive TherapyStem Cell TransplantationHematologyImmunologyDose-intensive CyclophosphamideDouble High-dose TherapyRadiation OncologyOncologyCell TransplantationHigh-dose MelphalanHealth Sciences